Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Milena A. Gianfrancesco,Kimme L. Hyrich,Sarah Al-Adely,Loreto Carmona,Maria I. Danila,Maria I. Danila,Laure Gossec,Zara Izadi,Lindsay Jacobsohn,Patricia P. Katz,Saskia Lawson-Tovey,Elsa F Mateus,Stephanie Rush,Gabriela Schmajuk,Julia F. Simard,Anja Strangfeld,Laura Trupin,Katherine D Wysham,Suleman Bhana,Wendy Costello,Rebecca Grainger,Jonathan S. Hausmann,Jonathan S. Hausmann,Jean W. Liew,Emily Sirotich,Paul Sufka,Zachary S. Wallace,Jinoos Yazdany,Pedro Machado,Philip Robinson,Philip Robinson +30 more
Reads0
Chats0
TLDR
It is found that glucocorticoid exposure of ≥10 mg/day is associated with a higher odds of hospitalisation and anti-TNF with a decreased odds ofospitalisation in patients with rheumatic disease.Abstract:
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly understood. The aim was to examine demographic and clinical factors associated with COVID-19 hospitalisation status in people with rheumatic disease. Methods Case series of individuals with rheumatic disease and COVID-19 from the COVID-19 Global Rheumatology Alliance registry: 24 March 2020 to 20 April 2020. Multivariable logistic regression was used to estimate ORs and 95% CIs of hospitalisation. Age, sex, smoking status, rheumatic disease diagnosis, comorbidities and rheumatic disease medications taken immediately prior to infection were analysed. Results A total of 600 cases from 40 countries were included. Nearly half of the cases were hospitalised (277, 46%) and 55 (9%) died. In multivariable-adjusted models, prednisone dose ≥10 mg/day was associated with higher odds of hospitalisation (OR 2.05, 95% CI 1.06 to 3.96). Use of conventional disease-modifying antirheumatic drug (DMARD) alone or in combination with biologics/Janus Kinase inhibitors was not associated with hospitalisation (OR 1.23, 95% CI 0.70 to 2.17 and OR 0.74, 95% CI 0.37 to 1.46, respectively). Non-steroidal anti-inflammatory drug (NSAID) use was not associated with hospitalisation status (OR 0.64, 95% CI 0.39 to 1.06). Tumour necrosis factor inhibitor (anti-TNF) use was associated with a reduced odds of hospitalisation (OR 0.40, 95% CI 0.19 to 0.81), while no association with antimalarial use (OR 0.94, 95% CI 0.57 to 1.57) was observed. Conclusions We found that glucocorticoid exposure of ≥10 mg/day is associated with a higher odds of hospitalisation and anti-TNF with a decreased odds of hospitalisation in patients with rheumatic disease. Neither exposure to DMARDs nor NSAIDs were associated with increased odds of hospitalisation.read more
Citations
More filters
Journal ArticleDOI
Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis- A population-based cohort study.
Khalaf Kridin,Khalaf Kridin,Yochai Schonmann,Giovanni Damiani,Avi Peretz,Erez Onn,Dana Tzur Bitan,Arnon D. Cohen,Arnon D. Cohen +8 more
TL;DR: In this article, a population-based cohort study was conducted to assess the risk of coronavirus disease 2019 (COVID-19) and its complications among patients with psoriasis treated by TNFis.
Journal ArticleDOI
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
Amit Saxena,Allison Guttmann,Mala Masson,Mimi Y. Kim,Rebecca H. Haberman,Rochelle Castillo,Jose U. Scher,Kristina K Deonaraine,Alexis J Engel,H. Michael Belmont,Ashira D Blazer,Jill P. Buyon,Ruth Fernandez-Ruiz,Peter M. Izmirly,Samrachana Adhikari,Jordan E. Axelrad,Natalie Azar,Rebecca B Blank,Lenore Brancato,Konstantin Brodetskiy,Lily Cao,Philip M. Carlucci,Steven Carsons,Miao Chang,Shannon Chang,Alan Chen,Michael Colin,Lauren Fried,Bruce Garner,Avram Goldberg,Brian D. Golden,Michael Golpanian,Mayce Haj-Ali,Jessica Hoey,Yamen Homsi,Simon Hong,David Hudesman,Nazia Hussain,Brian Jaros,Susan Katz,Avani Kolla,Euna Lee,Sicy Lee,Robert Lesser,Robin Lipschitz,Eileen Lydon,Fardina Malik,Keshav Mangalick,Kavini Mehta,Anang Modi,Andrea L. Neimann,Joshua Novack,Julie Nusbaum,Connor Peterson,Andres Piatti,Benjamin Plotz,Andrew Porges,Lindsey Quintana,Paula Rackoff,Deborah Ramirez,Lauren Rangel,Soumya M. Reddy,Kimberly Robins,Pamela Rosenthal,Jonathan Samuels,Sabina Sandigursky,Vaish Sekar,Shruti Shankar,Harry Shen,Stephen Smiles,Craig Smuda,Bruce Solitar,Gary Solomon,Jennifer Stein,Alexa Steuer,Janine Sullivan,Katerina Svigos,Andrea B. Troxel,Stelios Viennas,Lauren Wong,Di Yan,Kaitlyn Yin,Trevor Young,Gary Zagon +83 more
TL;DR: In this paper, the presence of SARS-CoV-2 IgG antibodies in patients with systemic lupus erythematosus (SLE) with or without previous COVID-19-related symptoms or RT-PCR-confirmed SARS CoV2 infection was evaluated.
Journal ArticleDOI
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.
Isabelle Amigues,Alexander H. Pearlman,Aarat Patel,Pankti Reid,Philip Robinson,Rashmi Sinha,Alfred Hj Kim,Taryn Youngstein,Arundathi Jayatilleke,Maximilian F. Konig +9 more
TL;DR: Despite similarities, COVID-19-CSS appears to be distinct from HLH, MAS, and CRS, and the application of HLH diagnostic scores and criteria to CO VID-19 is not supported by emerging data.
Journal ArticleDOI
COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre.
Natasha Cleaton,Sabrina Raizada,Nick Barkham,Srinivasan Venkatachalam,Tom Sheeran,Tochukwu Adizie,Hem Raj Sapkota,Baldev M Singh,James Bateman +8 more
TL;DR: To complement Gianfresesco's work, data from a large rheumatology cohort in the UK evaluating impact of treatment group and shielding on COVID-19 incidence is presented and data on impact of therapy and shielded on health-related quality of life (HRQoL) is presented.
Journal ArticleDOI
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
Saikat Dewanjee,Ramesh Kandimalla,Rajkumar Singh Kalra,Chandrasekhar Valupadas,Jayalakshmi Vallamkondu,Viswakalyan Kolli,Sarbani Dey Ray,Arubala P. Reddy,P. Hemachandra Reddy +8 more
TL;DR: In this paper, a detailed review of immediate challenges and key recommendations for anti-rheumatic drugs in the COVID-19 setting was presented for better clinical monitoring and management of RA patients.
References
More filters
Journal ArticleDOI
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more
TL;DR: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu,Jennifer M. McGoogan +1 more
TL;DR: Hospitalised COVID-19 patients are frequently elderly subjects with co-morbidities receiving polypharmacy, all of which are known risk factors for d
Journal ArticleDOI
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta,Daniel F. McAuley,Michael Brown,Emilie Sanchez,Rachel Tattersall,Rachel Tattersall,Jessica J Manson +6 more
TL;DR: Re-analysis of data from a phase 3 randomised controlled trial of IL-1 blockade (anakinra) in sepsis, showed significant survival benefit in patients with hyperinflammation, without increased adverse events.
Related Papers (5)
Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby,Wei Shen Lim,Jonathan Emberson,M Mafham,Jennifer L Bell,Louise Linsell,Natalie Staplin,Christopher E. Brightling,Andrew Ustianowski,E Elmahi,B Prudon,Christopher A Green,Timothy Felton,David Chadwick,K Rege,C Fegan,Lucy C Chappell,Saul N. Faust,Thomas Jaki,Katie Jeffery,Alan A Montgomery,Kathryn M Rowan,Edmund Juszczak,J K Baillie,Richard Haynes,Martin J Landray +25 more